CSIMarket
 


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd 's Long Term Debt to Equity

PPBT's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




PPBT Long Term Debt to Equity (Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Change -27.66 % -27.66 % -27.66 % -27.66 % -18.36 %
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
Overall Ranking
Seq. Equity Change 0 % 0 % 0 % -27.66 % 0 %
Seq. Long Term Debt Change - - - - -



Comment on PPBT Long Term Debt to Equity in the forth quarter 2022
In the forth quarter 2022 Purple Biotech Ltd did not have Long Term Debt .

Within Major Pharmaceutical Preparations industry Purple Biotech Ltd achieved the lowest Long Term Debt to Equity in the forth quarter 2022. While total ranking remained the same in the forth quarter 2022 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt PPBT´s has?
What is the structure of PPBT´s Equity?
Long Term Debt to Equity forth quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Purple Biotech Ltd 's Equity $ 47 Millions Visit PPBT's Balance sheet
Purple Biotech Ltd 's Long Term Debt $ 0 Millions Visit PPBT's Balance sheet
Source of PPBT's Sales Visit PPBT's Sales by Geography


Cumulative Purple Biotech Ltd 's Long Term Debt to Equity

PPBT's Long Term Debt to Equity for the trailling 12 Months

PPBT Long Term Debt to Equity

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity TTM Growth -27.66 % -27.66 % -27.66 % -27.66 % -18.36 %
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth 0 % 0 % 0 % -27.66 % 0 %
Seq. Long Term Debt TTM Growth - - - - -


TTM Long Term Debt to Equity Comment
On the trailing twelve months basis During the twelve months ending IV Quarter 2022 Purple Biotech Ltd did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry PPBT recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt PPBT´s has?
What is the structure of PPBT´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


TTM Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityDec 31 2022 MRQ Long Term DebtDec 31 2022 MRQ Equity

Date modified: 2023-03-23T13:12:32+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071